Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

BWXT $   $  
As of . Minimum 20 minute delay.

News

BWXT Enters Agreement to Acquire Kinectrics, a Leading Service Provider to the Global Nuclear Market

07 January 2025

BWX Technologies, Inc. (NYSE: BWXT) today announced that it has entered into an agreement to acquire Kinectrics, Inc.


BWXT Canada and Westinghouse Sign MOU for AP1000® and AP300™ Projects

12 December 2024

BWXT Canada, Ltd. (“BWXT”), a subsidiary of BWX Technologies, Inc., and Westinghouse Electric Company announced today that they have signed a memorandum of understanding (MOU) to support nuclear new-build projects in Canada and globally. Under the agreement, BWXT has the potential to manufacture key AP1000® and AP300™ reactor components, including steam generators, reactor vessels, pressure vessels and heat exchangers.


BWXT Named First Member of GE Vernova Nuclear’s Small Modular Reactor Supplier Group

29 April 2024

BWXT Canada Ltd., a subsidiary of BWX Technologies, Inc. has been selected as the first qualified supply chain company to join the GE Vernova nuclear business’ supplier group that will advance the global deployment of the BWRX-300 small modular reactor (SMR).


BWXT Announces Expansion of Cambridge Manufacturing Plant to Support Global Nuclear Power Market

19 April 2024

BWX Technologies, Inc. (NYSE: BWXT) announced an investment to expand its Cambridge manufacturing plant.


BWXT Canada Joins Canadians for CANDU® Campaign

11 April 2024

BWXT Canada Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT), has joined the Canadians for CANDU Campaign.


BWXT Medical Expands Collaboration with Fusion Pharmaceuticals Through Strengthened Actinium Supply and Access to Generator Technology

16 November 2023

(OTTAWA, Ontario – November 16, 2023) – BWXT Medical Ltd. and Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) today announced that the companies have entered into an agreement for the supply of generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.



Scott Gray Appointed Executive Vice President, Project & Field Services for Commercial Operations

30 March 2022

(CAMBRIDGE, ON. – March 30, 2022) – BWX Technologies, Inc. (NYSE: BWXT) today announced that it has named Scott Gray to the position of Executive Vice President of Projects & Field Services for BWXT’s Commercial Operations segment (BWXT) effective April 1, 2022.


BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225

16 September 2021

(OTTAWA, Ontario – September 16, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies (TRTs) and other innovative products.


BWXT Awarded CA$40 Million Contract to Supply Heat Exchangers for Bruce Power

19 August 2021

BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from Bruce Power valued at approximately CA$40 million to supply four moderator heat exchangers.

Press Contact:

John Dobken
+1 202.641.3013
jcdobken@bwxt.com

Archive

Tags